Improving Disease Management through Innovative Microbiology Solutions

DeepChek®
Genotyping through NGS & Sanger Sequencing
  • HIV
  • SARS CoV-2
  • HCV
  • TB
  • 16S RNA
More information
UltraGene®
RT-PCR Solutions for Molecular Detection
  • SARS CoV-2
  • Dengue
  • Zika
More information
Digital Solutions
  • Analysis software
  • Data hosting
  • Lab automation
  • Nadis® (Computerized medical record)
More information
Microbiological Specimen Transport and Collection Kits
  • Saliva Preservation Kits
  • Wastewater Collection Kit
  • Surface Collection Kit
  • Inactivation and Preservation Solution
More information
Instruments & Consumables
  • DNA/RNA extraction
  • Real-time PCR systems
  • Liquid handling robots
  • Next-Generation Sequencing (NGS)
  • SANGER sequencing
More information

ABL Diagnostics Showcases Scientific Progress at EMHH 2026, Supporting Strategic Positioning in Molecular Technologies

https://www.einpresswire.com/article/918127065/abl-diagnostics-showcases-scientific-progress-at-emhh-2026-supporting-strategic-positioning-in-molecular-technologies

Read More

ABL Diagnostics Advances Platform-Agnostic NGS Strategy Through DeepChek® Verification on Element Biosciences’ AVITI™

https://www.einpresswire.com/article/918135269/abl-diagnostics-advances-platform-agnostic-ngs-strategy-through-deepchek-verification-on-element-biosciences-aviti

Read More

ABL Diagnostics Deepens Laboratory Footprint with Launch of HybridChek for HIV and Tuberculosis Whole Genome Sequencing

https://www.einpresswire.com/article/917550254/abl-diagnostics-deepens-laboratory-footprint-with-launch-of-hybridchek-for-hiv-and-tuberculosis-whole-genome-sequencing

Read More

ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026 (EN)

https://www.businesswire.com/news/home/20260601791272/en/ABL-Diagnostics-Presents-Its-Financial-Roadmap-and-Growth-Outlook-for-2026

Read More

Subscribe to our newsletter

Scroll to Top